Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - WAY-309060

WAY-309060

CAS No. 309951-18-6

WAY-309060 ( —— )

Catalog No. M28814 CAS No. 309951-18-6

WAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	36	Get Quote
5MG	58	Get Quote
10MG	87	Get Quote
25MG	178	Get Quote
50MG	295	Get Quote
100MG	484	Get Quote
200MG	691	Get Quote
500MG	1035	Get Quote
1G	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

WAY-309060
Note

Research use only, not for human use.
Brief Description

WAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.
Description

WAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.
Synonyms

——
Pathway

Chromatin/Epigenetic
Target

Epigenetic Reader Domain
Recptor

——
Research Area

——
Indication

——

Chemical Information

CAS Number

309951-18-6
Formula Weight

262.3
Molecular Formula

C13H14N2O4
Purity

>98% (HPLC)
Solubility

——
SMILES

Cc1cc(NC(c(cc2)cc(OC)c2OC)=O)no1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.LEXICON PHARMACEUTICALS INC - US2012/65200, 2012, A1

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

IRAK4-IN-1

IRAK4-IN-1 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor with an IC50 of 7 nM.
CBP/EP300-IN-1

CBP/EP300-IN-1 is a CBP/EP300 bromodomain inhibitor.
BAZ1A-IN-1

BAZ1A-IN-1 is a potent BAZ1A inhibitor with the KD value of 0.52 μM for the BAZ1A bromodomain. BAZ1A-IN-1 shows good anti-survival activity against cancer cell lines with high BAZ1A expression, but weak or no activity against cancer cells with low BAZ1A expression.

Sign In Join Free